Miglitol is an alpha-glucosidase inhibitor used in adults with type 2 diabetes to help control blood sugar alongside diet and exercise. Diaset 25 mg tablets are a brand of this medicine.
There are 3 brands of Miglitol listed in Bangladesh. 1 of them has a lower unit price than Diaset.
What is Diaset 25 mg Tablet?
Diaset 25 mg tablets contain miglitol, an alpha-glucosidase inhibitor. It works by slowing the breakdown of carbohydrates in the intestine, which reduces the rise in blood sugar after meals. It is used as an adjunct to diet and exercise in adults with type 2 diabetes mellitus. The doctor decides the dose and course for each person. Miglitol is not a fixed-dose medicine; the dose is adjusted gradually based on effectiveness and tolerance. It should be taken at the start of each main meal. The listed price is available on the site.
Uses of Diaset
Diaset is used in adults with type 2 diabetes mellitus, in addition to diet and exercise, to improve blood sugar control. It helps lower blood sugar levels after meals by delaying the digestion and absorption of carbohydrates. It may be prescribed alone or with other diabetes medicines. The doctor decides whether it is suitable and how it fits into your overall treatment plan. Always follow the doctor's advice on diet and exercise alongside this medicine.
How to use Diaset
Take Diaset exactly as your doctor prescribes. The doctor decides the dose and how often you take it; do not change the dose yourself. Miglitol is usually taken at the start of each main meal. Swallow the tablet with water. If you miss a dose, ask your doctor or pharmacist what to do. Do not stop taking it without talking to your doctor first. Follow your doctor's advice on diet and exercise, as these are important alongside the medicine.
Side effects of Diaset
Common side effects of miglitol include abdominal pain or discomfort, diarrhoea, flatulence, and skin rash. These are more likely when treatment is started and may lessen over time. If side effects are severe or do not go away, contact your doctor. Serious side effects are possible but not common. Ask your doctor or pharmacist about what to do if you experience any side effect. Do not ignore symptoms that worry you.
Safety and precautions
Before taking Diaset, tell your doctor if you have kidney problems, are pregnant or planning pregnancy, or are breastfeeding. Miglitol is not suitable for people with diabetic ketoacidosis, inflammatory bowel disease, colonic ulceration, partial intestinal obstruction, chronic intestinal diseases with digestion or absorption problems, or conditions that may worsen with increased intestinal gas. The risk of low blood sugar is higher if you also take insulin or certain other diabetes medicines. During illness, surgery, or stress, ask your doctor for advice. The doctor will decide if the medicine is appropriate for you.
Frequently asked questions
What is Diaset used for and what kind of medicine is it?
Diaset contains miglitol, an alpha-glucosidase inhibitor. It is used in adults with type 2 diabetes, along with diet and exercise, to help control blood sugar levels. It works by slowing carbohydrate digestion and absorption after meals. The doctor decides if it is right for you.
Is Diaset safe in pregnancy or breastfeeding?
Miglitol is in pregnancy category B, meaning animal studies have not shown a risk to the fetus, but there are no controlled studies in pregnant women. It is not known if it passes into breast milk. Tell your doctor if you are pregnant, planning pregnancy, or breastfeeding. The doctor will decide if it is suitable for you.
What does the generic name miglitol mean?
Miglitol is the generic name of the active ingredient in Diaset. It belongs to a group of medicines called alpha-glucosidase inhibitors. These medicines work by blocking enzymes in the intestine that break down carbohydrates, which helps reduce blood sugar spikes after meals.
What is the price of Diaset?
The listed price is ৳ 10.07. For the most current price and availability, check the website or ask your pharmacist. Prices can vary, so confirm before purchasing.
Miglitol is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Pharmacology
Miglitol reversibly inhibits membrane-bound intestinal α-glucosidase enzymes which hydrolyse oligosaccharides and disaccharides to glucose and other monosaccharides in the small intestinal brush border. It delays carbohydrate breakdown, glucose absorption and reduces postprandial hyperglycaemia.
Dosage & Administration
There is no fixed dosage regimen for the management of diabetes mellitus with Miglitol Tablets or any other pharmacologic agent. Dosage of Miglitol must be individualized on the basis of both effectiveness and tolerance while not exceeding the maximum recommended dosage of 100 mg 3 times daily. Miglitol should be taken three times daily at the start of each main meal. Miglitol should be started at 25 mg, and the dosage gradually increased both to reduce gastrointestinaladverse effects and to permit identification of the minimum dose required for adequate glycemic control of the patient. During treatment initiation and dose titration one-hour postprandial plasma glucose may be used to determine the therapeutic response to Miglitol and identify the minimum effective dose for the patient.
Thereafter, glycosylated hemoglobin should be measured at intervals of approximately 3 months. The therapeutic goal should be to decrease both postprandial plasma glucose and glycosylated hemoglobin levels to normal or near normal by using the lowest effective dose of Miglitol, either as monotherapy or in combination with a sulfonylurea.
Initial Dosage: The recommended starting dosage of Miglitol is 25 mg, given orally three times daily at the start of each main meal. However, some patients may benefit by starting at 25 mg once daily to minimize gastrointestinal adverse effects, and gradually increasing the frequency of administration to 3 times daily.
Maintenance Dosage: The usual maintenance dose of Miglitol is 50 mg taken 3 times daily, although some patients may benefit from increasing the dose to 100 mg 3 times daily. To allow adaptation to potential gastrointestinal adverse effects, it is recommended that Miglitol therapy be initiated at a dosage of 25 mg 3 times daily, then gradually titrated upward to allow adaptation. After 4 to 8 weeks of the 25 mg 3 times daily regimen, the dosage should be increased to 50 mg 3 times daily for approximately three months, following which a glycosylated hemoglobin level should be measured to assess therapeutic response. If at that time, the glycosylated hemoglobin level is not satisfactory, the dosage may be further increased to 100 mg 3 times daily, the maximum recommended dosage.
Maximum Dosage: The maximum recommended dosage of Miglitol is 100 mg 3 times daily. In one clinical trial, 200 mg 3 times daily gave additional improved glycemic control but increased the incidence of the gastrointestinal symptoms described above.
Patients Receiving Sulfonylureas: Sulfonylurea agents may cause hypoglycemia. There was no increased incidence of hypoglycemia in patients who took Miglitol in combination with sulfonylurea agents compared to the incidence of hypoglycemia in patients receiving sulfonylureas alone in any clinical trial. However, Miglitol given in combination with a sulfonylurea will cause a further lowering of blood glucose and may increase the risk of hypoglycemia due to the additive effects of the two agents. If hypoglycemia occurs, appropriate adjustments in the dosage of these agents should be made
Interaction
Concomitant use with insulin increases the risk of hypoglycaemia. Intestinal adsorbents (e.g. charcoal) and carbohydrate-splitting digestive enzyme supplements (e.g. amylase, pancreatin) may reduce glycaemic effects. May significantly reduce the bioavailability of ranitidine and propranolol.
Contraindications
Patient with diabetic ketoacidosis, inflammatory bowel disease, colonic ulceration, partial intestinal obstruction or predisposition to this condition, chronic intestinal diseases associated with marked disorders of digestion or absorption and co-existing conditions that may deteriorate as a result of increased intestinal gas formation.
Side Effects
Abdominal pain or discomfort, diarrhoea, flatulence, skin rash.
Pregnancy & Lactation
Category B: Either animal-reproduction studies have not demonstrated a fetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is no evidence of a risk in later trimesters).
Precautions & Warnings
Patient exposed to stress (e.g. fever, trauma, infection, surgery). Renal impairment. Pregnancy and lactation.
Alternative brands of Miglitol
Other brands with the same generic name, cheapest first.